Madrigal Pharmaceuticals had a revenue of 212.80M in the quarter ending Jun 30, 2025, with 55.05%. This bring the company's revenue in the last twelve months to 515.55M, Decreased 62.44%. In the fiscal year ending Dec 31, 2024, Madrigal Pharmaceuticals had annual revenue of 180.13M with Infinity% growth.